Background: A telemedicine care concept based on telephone contacts and individualized text messages was developed for patients with mental disorders to continue treatment after therapy in a psychiatric day hospital. The primary objective of this study was to evaluate the effectiveness of the telemedicine interventions. Methods: The study had a 3-armed, randomized design with 2 intervention arms (intervention 1: telephone contacts; intervention 2: telephone contacts and short text messages; both took place over a period of 6 months and in addition to usual care), and a control group with usual care. Primary outcomes were 18-item Brief Symptom Inventory (BSI-18) scores for anxiety, depression and somatization. All participants were recruited from psychiatric day hospitals. The study was registered in the German Clinical Trials Register (DRKS00000662). Results: 113 participants were analyzed 6 months after starting the intervention. The average BSI-18 anxiety score after 6 months was -2.04 points lower in intervention group 2 than in the control group (p value: 0.042). The difference in BSI depression score between these two groups was marginally significant (p value: 0.1), with an average treatment effect of -1.73. In an exploratory sensitivity analysis restricted to the 75% of patients with the highest symptom scores at baseline, intervention group 1 yielded a significant effect for anxiety and depression compared to the control group (p = 0.036 and 0.046, respectively). Conclusions: Telemedicine provides a novel option in psychiatric ambulatory care with statistically significant effects on anxiety. A positive tendency was observed for depression, especially in cases with higher symptom load at baseline.

1.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
2.
Jacobi F, Wittchen HU, Holting C, Höfler M, Pfister H, Müller N, Lieb R: Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004;34:597-611.
3.
Cepoiu M, McCusker J, Cole MG, Sewitch M, Belzile E, Ciampi A: Recognition of depression by non-psychiatric physicians - a systematic literature review and meta-analysis. J Gen Intern Med 2008;23:25-36.
4.
Wittchen HU, Hofler M, Meister W: Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? Int Clin Psychopharmacol 2001;16:121-135.
5.
Schulz H, Barghaan D, Harfst T, Koch U: Psychotherapeutische Versorgung, Gesundheitsberichterstattung des Bundes. Berlin, Robert-Koch-Institut, 2008, vol 41.
6.
Gunther OH, Friemel S, Bernert S, Matschinger H, Angermeyer MC, Konig HH: The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Psychiatr Prax 2007;34:292-301.
7.
Grabe HJ, Baumeister S, John U, Freyberger HJ, Völzke H: Association of mental distress with health care utilization and costs: a five-year observation in a general population. Soc Psychiatry Psychiatr Epidemiol 2009;44:835-844.
8.
García-Lizana F, Muñoz-Mayorga I: What about telepsychiatry? A systematic review. Prim Care Companion J Clin Psychiatry 2010;12:pii:PCC.09m00831. DOI: 10.4088/PCC.09m00831whi.
9.
Hilty DM, Luo JS, Morache C, Marcelo DA, Nesbitt TS: Telepsychiatry: an overview for psychiatrists. CNS Drugs 2002;16:527-548.
10.
Norman S: The use of telemedicine in psychiatry. J Psychiatr Ment Health Nurs 2006;13:771-777.
11.
Andersson G, Paxling B, Roch-Norlund P, Östman G, Norgren A, Almlöv J, Georén L, Breitholtz E, Dahlin M, Cuijpers P, Carlbring P, Silverberg F: Internet-based psychodynamic versus cognitive behavioral guided self-help for generalized anxiety disorder: a randomized controlled trial. Psychother Psychosom 2012;81:344-355.
12.
Simon GE, Ludman EJ, Tutty S, Operskalski B, Von Korff M: Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA 2004;292:935-942.
13.
Mohr DC, Ho J, Duffecy J, Reifler D, Sokol L, Burns MN, Jin L, Siddique J: Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA 2012;307:2278-2285.
14.
Mohr DC, Vella L, Hart S, Heckman T, Simon G: The effect of telephone-administered psychotherapy on symptoms of depression and attrition: a meta-analysis. Clin Psychol (New York) 2008;15:243-253.
15.
Fortney JC, Pyne JM, Mouden SB, Mittal D, Hudson TJ, Schroeder GW, Williams DK, Bynum CA, Mattox R, Rost KM: Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial. Am J Psychiatry 2013;170:414-425.
16.
Rollman BL, Belnap BH, Mazumdar S, Houck PR, Zhu F, Gardner W, Reynolds CF 3rd, Schulberg HC, Shear MK: A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry 2005;62:1332-1341.
17.
Gensichen J, von Korff M, Peitz M, Muth C, Beyer M, Güthlin C, Torge M, Petersen JJ, Rosemann T, König J, Gerlach FM: PRoMPT (PRimary care Monitoring for depressive Patients Trial). Case management for depression by health care assistants in small primary care practices: a cluster randomized trial. Ann Intern Med 2009;151:369-378.
18.
van den Berg N, Grabe HJ, Freyberger HJ, Hoffmann W: A telephone- and text-message based telemedical care concept for patients with mental health disorders - study protocol for a randomized, controlled study design. BMC Psychiatry 2011;11:30.
19.
Meyer J, Ostrzinski S, Fredrich D, Havemann C, Krafczyk J, Hoffmann W: Efficient data management in a large-scale epidemiology research project. Comput Methods Programs Biomed 2012;107:425-435.
20.
Derogatis LR, Melisaratos N: The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13:595-605.
21.
Spitzer C, Hammer S, Löwe B, Grabe HJ, Barnow S, Rose M, Wingenfeld K, Freyberger HJ, Franke GH: The short version of the Brief Symptom Inventory (BSI-18): preliminary psychometric properties of the German translation. Fortschr Neurol Psychiatr 2011;79:517-523.
22.
Senn S: Change from baseline and analysis of covariance revisited. Stat Med 2006;25:4334-4344.
23.
White IR, Carpenter J, Horton NJ: Including all individuals is not enough: lessons for intention-to-treat analysis. Clin Trials 2012;9:396-407.
24.
Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, Tasch ET: Telephone-administered psychotherapy for depression. Arch Gen Psychiatry 2005;62:1007-1014.
25.
Cox CE, Porter LS, Buck PJ, Hoffa M, Jones D, Walton B, Hough CL, Greeson JM: Development and preliminary evaluation of a telephone-based mindfulness training intervention for survivors of critical illness. Ann Am Thorac Soc 2014;11:173-181.
26.
Plaisier I, de Bruijn JG, Smit JH, de Graaf R, Ten Have M, Beekman AT, van Dyck R, Penninx BW: Work and family roles and the association with depressive and anxiety disorders: differences between men and women. J Affect Disord 2008;105:63-72.
27.
Plaisier I, Beekman AT, de Bruijn JG, de Graaf R, Ten Have M, Smit JH, van Dyck R, Penninx BW: The effect of social roles on mental health: a matter of quantity or quality? J Affect Disord 2008;111:261-270.
28.
Ludman EJ, Simon GE, Grothaus LC, Luce C, Markley DK, Schaefer J: A pilot study of telephone care management and structured disease self-management groups for chronic depression. Psychiatr Serv 2007;58:1065-1072.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.